Skip to main content
Long-term safety of early discontinuation of antiseizure medication after resolution of acute provoked neonatal seizures.
Characterizing early behavioral and social-emotional problems in young children with SCN1A+ Dravet syndrome: Findings from the ENVISION prospective natural history study.
Cognitive stagnation and executive function deficits in young children with SCN1A+ Dravet syndrome: Detailed characterization of onset, progression, and impact in the ENVISION natural history study.
Postneonatal epilepsy after acute provoked neonatal seizures: Incidence, predictors, and clinical burden in a multicenter cohort followed through early childhood.
Appropriate selection of participants in pediatric developmental and epileptic encephalopathy trials: Lessons learned and future opportunities.
MBOAT7 encephalopathy: Characterizing the neurology and epileptology.
Variants in ATP6V0C are associated with Dravet-like developmental and epileptic encephalopathy.
Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome.
Machine learning for forecasting initial seizure onset in neonatal hypoxic-ischemic encephalopathy.
Early-life epilepsy after acute symptomatic neonatal seizures: A prospective multicenter study.
